⌘K

Login Start Free

Home/Filings/4/0001213900-24-095931

4//SEC Filing

KIDRON NADAV 4

Accession 0001213900-24-095931

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Nov 7, 7:00 PM ET

Accepted

Nov 8, 4:30 PM ET

Size

5.6 KB

Accession

0001213900-24-095931

Insider Transaction Report

Form 4

Period: 2024-11-07

ORAMED PHARMACEUTICALS INC.ORMP

DirectorPresident and CEO

Transactions

Award
Common Stock
2024-11-07+45,000→ 1,826,098 total

Holdings

Common Stock
(indirect: By wholly-owned corporation)
126,000

Footnotes (1)

[F1]Represents Restricted Stock Units ("RSUs") that will vest on November 7, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001351779

Filing Metadata

Form type: 4
Filed: Nov 7, 7:00 PM ET
Accepted: Nov 8, 4:30 PM ET
Size: 5.6 KB

View on SEC.gov